Clinical trial
Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I…
NCT00020735 · Joel Nelson, MD, Other · Completed
Key facts
| NCT number | NCT00020735 |
|---|---|
| Title | Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer |
| Official title | A Phase II Randomized Controlled Clinical Trial Of The Antiestrogen GTx-006 In Subjects With Prostate Cancer |
| Lead sponsor | Joel Nelson, MD, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | toremifene, conventional surgery, neoadjuvant therapy |
| Enrollment | 45 |
| Start date | Apr 1, 2001 |
| Primary completion | Jan 1, 2005 |
| Completion | Jun 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: